The patients will have to take the vaccine and medication once a year, for five consecutive years. Myanmar health authorities commenced an Anti-elephantiasis campaign in 2019 for the country as a follow-up of last year's efforts.
Under the guidance of the Minister of Health, the Salingyi Township health department provided medication for the Elephantiasis disease carrying people who live in the Salingyi region. This program was conducted in the MYTCL owned and operated Mine Town Employee Emergency Hospital on 29th January, 2019. MYTCL health officials followed up again by visiting family's door-to-door to take the medicine, and to also provide a pamphlet with knowledge about symptoms, causes, and treatment. The nurses and health care assistants told people about the side effects of the vaccine, and warned people with high blood pressure, diabetes or asthma, pregnant women, lactating mothers, infants and people with chronic diseases such as liver infection, and even heart disease. People with these current conditions should avoid the vaccine, because it can cause life-threatening side effects such as acute inflammation of the brain, visual loss, disorder of the eyes due to bleeding in the retina, and severe skin allergies.